Hyperspectral Imaging System Global Market Report 2023 – By Product, Cameras, Acessories), By Technology (Push Broom, Snapshot, Other Technologies), By Application (Military Surveillance, Remote Sensing, Life Sciences And Medical Diagnostics, Machine Vision And Optical Sorting, Other Applications), By End user (Food And Agriculture, Health care, Defense, Mining And Metrology, Other End Users) – Market Size, Trends, And Global Forecast 2023-2032

The magnetic resource imaging devices and equipment market consists of sales of magnetic resource imaging systems devices and equipment and related services. Magnetic resonance imaging (MRI) systems are imaging machines used to form pictures of inflammation or infection in an organ, degenerative diseases, strokes, musculoskeletal disorders, tumors, and other irregularities that exist in tissue or organs in a body. MRI systems use a fixed or static magnetic field and radio frequency signals to visualize anatomy, tissue characteristics, vascular flow, chemical composition of tissues, and perfusion and diffusion of tissues.

The global magnetic resonance imaging devices and equipment market is expected to decline from $8.1 billion in 2019 to $6.6 billion in 2020 at a compound annual growth rate (CAGR) of -18.8%. The decline is mainly due to the COVID-19 outbreak and the measures to contain it. The governments across the countries prioritized covid-19 screening and imaging is not routinely used to screen for COVID-19. Also, most of the factories manufacturing diagnostic imaging equipment such as X-ray systems, ultrasound systems, computed tomography (CT) scanners, and MRI systems and/or their components, are currently shutdown inorder to keep the staff safe and contain the spread. The market is then expected to recover and grow at a CAGR of 6.2% from 2021 and reach $10.2 billion in 2023.

In 2018, North America was the largest region in the magnetic resonance imaging devices and equipment market. This region is expected to remain the largest during the next five years. The magnetic resonance imaging devices and equipment market in Asia Pacific is forecasted to register the highest CAGR during 2018-2023.

Changes in the lifestyle, technological advancement and increase in number of chronic diseases are increasing the demand for the diagnostics, driving the growth of MRI systems market. Magnetic resonance imaging (MRI) systems are used to produce three dimensional detailed anatomical images of the human body facilitating diagnosis, disease detection and treatment monitoring. The rising health concerns are increasing the demand for medical imaging technologies in healthcare centers for diagnosis. For instance, in India, 150,000 health and wellness centers with a budget of $ 1.8 billion enable the healthcare system more accessible. Increasing health consciousness and importance to health insurance is also causing significant growth in the market. For instance, in the USA, the number of uninsured dropped from 48.6 million in 2010 to 29.3 million in 2017 indicating an increase in the health concerns of the people.

Strict approvals and regulations by government bodies such as US Food and Drug Administration (FDA) is hampering the growth of magnetic resonance imaging systems, devices and equipment market. MRI systems manufacturers are required to comply several regulations in the form of device quality check, labeling, premarket approval, device investigation and reporting, apart from the regular registration process. Due to these stringent regulations, many manufacturers prefer to outsource the manufacturing to other countries where no such regulations are imposed. For instance, in July 2017, the European Medicines Agency (EMA), restricted the use of some linear gadolinium agents used in MRI body scans and to suspend the authorizations of others, as the gadolinium deposits are found in the brain after MRI scans. EMA has recommended these restrictions and suspensions in order to prevent any risks that could potentially be associated with gadolinium brain deposition.

Companies in the magnetic resonance imaging devices and equipment market are increasingly investing in advanced MRI imaging technologies to enhance their diagnosis and to reduce orders for rescans. The advanced MRI systems such as Multi contract MRI scanners, silent MRI Scanning technologies and others allow radiologists to modify patient`s image contrast after scanning, which is not possible with conventional imaging systems. For instance, in October 2017, the FDA cleared the first 7T MRI system, The Magnetom Terra from Siemens Healthineers, to strengthen the static magnetic field in the USA. Companies in the industry are collaborating to enhance technological advancements in the MRI systems and devices market. In September 2016, GE Healthcare collaborated with SyntheticMR AB to launch MAGiC (MAGnetic resonance image Compilation) software, the industry’s multi-contrast MRI system.

The EU agencies and US-FDA require 3 to 7 years along with all parts of the registration dossier to be submitted to approve the medical devices. The US-FDA assess each technical section for 6 months which may increase to another 6 months cycle if questions/concerns are raised. However, the technical sections’ assessment is done simultaneously and therefore the manufacturers should identify the time taking processes and plan the work accordingly and plan estimated date of approval. Also, the license validity and renewal of the application in EU region takes a toll on the manufacturer and adds to the existing regulatory burden. Therefore, the manufacturers of MRI systems, devices and equipment should plan well, communicate effectively in order to minimize the costs and reduce timelines.

Electrophysiology devices and equipment are used in the diagnosis and treatment of heart rhythm disorders through electrical activity. The main product types in the electrophysiology devices and equipment are electrophysiology ablation catheters, electrophysiology diagnostic catheters, and electrophysiology lab systems. Electrophysiology ablation catheters measure the electrical activity of the heart and diagnose abnormal heart rhythm. The various monitoring devices involved are electrocardiograph (ECG), electroencephalograph (EEG), electrocorticography (ECoG), electromyography (EMG), electroretinographic (ERG), electrooculography (EOG), Holter monitoring devices, X-ray systems, imaging and 3D mapping systems, and diagnostic electrophysiology catheters that are used in indication analysis of atrioventricular nodal reentry tachycardia (AVERT), Wolff-Parkinson-white syndrome (WPW), atrial flutter, and atrial fibrillation. The various end-users of electrophysiology devices and equipment are used in hospitals, diagnostic centres, and clinics. The global electrophysiology devices and equipment market is segmented - 1) By Product Type: Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Lab Systems 2) By Monitoring Device Type: Electrocardiograph (ECG), Electroencephalograph (EEG), Electrocorticograph (ECoG), Electromyograph (EMG), Electroretinograph (ERG), Electrooculograph (EOG), Holter Monitoring Devices, X-Ray Systems, Imaging and 3D Mapping Systems, Diagnostic Electrophysiology Catheters 3) By Indication Analysis: Atrioventricular Nodal Reentry Tachycardia (AVNRT), Wolff-Parkinson-White Syndrome (WPW), Atrial Flutter, Atrial Fibrillation 4) By End-Users: Hospitals, Diagnostic centers, Clinics The global electrophysiology devices and equipment market size will grow from $5.43 billion in 2022 to $5.94 billion in 2023 at a compound annual growth rate (CAGR) of 9.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the electrophysiology devices and equipment is expected to grow to $8.07 billion in 2027 at a CAGR of 7.9%. An increase in the prevalence rate of cardiovascular diseases (CVD) forms one of the major drivers for the industries operating in the electrophysiology devices and equipment market. CVD cases remain the leading cause of death across the globe, which increases the demand for a quick and effective treatment of the disease, thus increasing the demand for electrophysiology devices. According to the Centers for Disease Control and Prevention (CDC), in 2020, 697,000 people died from heart diseases which was almost 1 in every 5 deaths. By 2030, 12.1 million people in the United States will suffer from atrial fibrillation, which is the most common type of heart arrhythmia. Major players in the electrophysiology devices and equipment market are St. Jude Medical, Boston Scientific Corporation, Abbott Laboratories, GE Healthcare, Philips Healthcare, Biotronik SE & Co. KG, Medtronic Inc., Biosense Webster, Microport Scientific Corporation, and Japan Lifeline Co. Lack of uniformity in the regulations governing the electrophysiology devices and equipment industry sometimes restricts the companies in the market from expanding globally, thereby hampering the market’s growth. The impact of individual country regulatory requirements can have huge implications for the availability of new electrophysiology devices and equipment. According to regulations in a few geographies, the manufacturers are required to conduct clinical trials (premarket and/or post-market) be either in whole or in part within a country. However, in markets such as Brazil, Japan, India, and China where local regulations are still in the nascent stage, the cost to run the trials is incurred by the manufacturers. For example, trials for devices like cardiac rhythm management (CRM) in multiple countries have less merit and do not reflect the true test results as it becomes difficult for the manufacturers to provide sufficient devices to run tests. To increase the profit margins and sales, the companies operating in the Electrophysiology (EP) devices and equipment industry are coming up with new technologies aimed towards improving EP mapping and localization technology. EP mapping is a procedure used to diagnose the origins of abnormal heart rhythms. This procedure uses an electrically sensitive catheter. With improved mapping technologies it becomes easy to detect and locate abnormalities in the heart. For example, in June 2020, Boston Scientific launched its DIRECTSENSE™ technology for monitoring the effect of radiofrequency energy delivery during the cardiac ablation procedure. The Reuse of a single-use device (SUD) is permitted by The Medicines and Healthcare products Regulatory Agency (MHRA) may impact the electrophysiology devices and equipment market growth as few of the products within the market may be reused. The MHRA allows the reuse of electrophysiology catheters, however, the device should be adherent to the medical devices directive and should have a CE mark. The reuse or reprocessing of electrophysiology catheters by electrophysiology (EP) laboratories in the US help in reducing the costs of these devices and lessening the environmental burden of the discarded bio-waste materials. As there is no clear regulation on reuse in developing nations such as Africa., Asia, Eastern Europe, Central America, and South America, the electrophysiology devices and equipment market may face a few challenges. In September 2021, Boston Scientific, a company operating in electrophysiology devices and equipment acquired Lumenis for a deal amount of $1.07 billion. With this acquisition, Boston scientific company expands its portfolio in the US and Japan. Lumenis is a medical equipment company and a technology company based in Israel. North America was the largest region in global electrophysiology devices and equipment market in 2022. Western Europe was the second-largest region in global electrophysiology devices and equipment market share.The regions covered in the electrophysiology devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the electrophysiology devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The electrophysiology devices and equipment market consist of sales of ablation catheters, diagnostic catheters, mapping system, accessories, and other electrophysiology devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The electrophysiology devices and equipment market research report is one of a series of new reports from The Business Research Company that provides electrophysiology devices and equipment market statistics, including electrophysiology devices and equipment industry global market size, regional shares, competitors with a electrophysiology devices and equipment market share, detailed electrophysiology devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the electrophysiology devices and equipment industry. This electrophysiology devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medical and diagnostic laboratory services are services that provide diagnostics tests for various diseases. The tests are used for detecting if the person has encountered the disease. Medical and diagnostic laboratory services makes it possible to deliver prompt, affordable, and high-quality diagnostic services in secure settings. The main types of medical and diagnostic laboratory services are diagnostic imaging centres and medical laboratory services. A diagnostic imaging center is a service provider that offers technical or comprehensive diagnostic imaging services. The different expenditure types include public and private that are used in various applications such as cardiology, oncology, neurology, orthopedics, gastroenterology, gynecology, and others. The services are used by males and females. The global medical and diagnostic laboratory services market is segmented - 1) By Type: Diagnostic Imaging Centers, Medical Laboratory Services 2) By Application: Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, Other Applications 3) By End User Gender: Male, Female 4) By Type of Expenditure: Public, Private Subsegments Covered: Computer Tomography (CT-Scan) Centers, Medical Radiological Laboratories, Dental or Medical X-Ray Laboratories, Ultrasound Imaging Centers, Magnetic Resonance Imaging (MRI) Centers The global medical and diagnostic laboratory services market grew from $169.87 billion in 2022 to $183.84 billion in 2023 at a compound annual growth rate (CAGR) of 8.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The medical and diagnostic laboratory services market is expected to grow to $240.86 billion in 2027 at a CAGR of 7.0%. The rise in sedentary jobs, busy lifestyles, and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as cancer, diabetes, and cardiovascular diseases. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of chronic diseases such as diabetes. According to the World Health Organization, chronic disease prevalence rose by 57% globally, in 2020. Tests to diagnose these diseases include HbA1c tests for monitoring diabetes, biopsies, tumor marker tests, bone scans, MRI and CT scans for diagnosis of various cancers, electrocardiograms, chest X-rays, cardiac CT scans, and stress tests for detection of cardiovascular diseases. The increase in the prevalence of lifestyle diseases will increase the demand for tests to diagnose these diseases and thus will drive the medical and diagnostic laboratory services market during the forecast period. Major companies in the medical and diagnostic laboratory services market include Laboratory Corporation of America, Eurofins, Quest Diagnostics Incorporated, Sonic Healthcare Limited, Kaiser Permanente, RadNet, OPKO Health, Myriad Genetics, Charles River Laboratories, Inc., and NeoGenomics Laboratories, Inc. The medical and diagnostic laboratory services market is expected to limit by the rising prevalence of self-care diagnostic equipment. These tools can be used by patients without assistance from medical personnel, to diagnose particular disabilities or disorders. Common self-care diagnostic devices include glucose monitoring devices, blood pressure monitoring devices, sleep apnea monitors and temperature monitors. The ease of use of self-care devices has increased demand for them during the last decade and is expected to increase it further during the forecast period. Some virtual applications are also aiding in the diagnosis of certain health conditions. For instance, iPhone is working on an IOS accessory called Cue, which can be used as a home diagnostic kit. Self-care diagnostics is expected to have a negative impact on the traditional medical and diagnostic laboratory services market during the forecast period by reducing the need for laboratory testing for some basic tests. Medical and diagnostic laboratories are using biomarkers to measure health parameters associated with individual wellness. The health and well-being of individuals can be measured by using biomarkers to assess factors behind sleep disorders and symptoms of stress. Biomarkers such as cortisol, testosterone, and secretory IgA can indicate changes in the immune system relating to physical and mental conditions. This can be used by physicians to know the causative factors behind such conditions. This is a premium service primarily targeted at wealthy individuals and senior employees of corporations. North America was the largest region in the medical and diagnostic laboratory services market in 2022. Asia-Pacific was the second largest region in the medical and diagnostic laboratory services market. The regions covered in the medical and diagnostic laboratory services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical and diagnostic laboratory services market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The medical and diagnostic laboratory services market includes revenues earned by entities by providing diagnostic services such as diagnostic laboratory services, X-ray, CT scan, and Mammography. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The medical and diagnostic laboratory services market research report is one of a series of new reports from The Business Research Company that provides medical and diagnostic laboratory services market statistics, including medical and diagnostic laboratory services industry global market size, regional shares, competitors with a medical and diagnostic laboratory services market share, detailed medical and diagnostic laboratory services market segments, market trends and opportunities, and any further data you may need to thrive in the medical and diagnostic laboratory services industry. This medical and diagnostic laboratory services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Nuclear imaging devices and equipment are used in the diagnosis of diseases by using small amounts of radioactive substances in the patients and are used in a wide range of medical applications including cardiology, obstetrics/gynecology, vascular, urology, and other medical applications. The main product types in the nuclear imaging devices and equipment are SPECT systems, PET systems, and planar scintigraphy. The SPECT scan is used to capture the images and create 3D scanning. These are used for various applications such as oncology, cardiology, neurology, other applications (orthopedics, urology, thyroid-related disorders, and gastroenterology) that are used in hospitals, imaging centres, academic & research institutes, other end users (pharmaceutical/biotechnology companies and CROs). The global nuclear imaging devices and equipment market is segmented - 1) By product type: SPECT systems, PET systems, Planar Scintigraphy, 2) By application: Oncology, Cardiology, Neurology, Other Applications (Orthopedics, Urology, Thyroid-related Disorders, and Gastroenterology) 3) By end user: Hospitals, Imaging Centers, Academic & Research Institutes, Other End Users (Pharmaceutical/Biotechnology Companies and CROs) The global nuclear imaging devices and equipment market size will grow from $4.02 billion in 2022 to $4.22 billion in 2023 at a compound annual growth rate (CAGR) of 5.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global nuclear imaging devices and equipment is expected to grow from $4.99 billion in 2027 at a CAGR of 4.3%. The nuclear imaging devices and equipment market is being driven by increasing incidences and prevalence of diseases such as cancer, heart disease, gastrointestinal, endocrine, and neurological disorders. Such diseases are diagnosed in relatively early stages by nuclear imaging equipment as compared to other equipment. For instance, according to the American Cancer Society 2020, in the United States, 1.8 million new cancer cases are diagnosed and 606,520 cancer deaths in the United States, many of which have been diagnosed by nuclear imaging devices and equipment. Major players in the market are Toshiba Medical Systems Corporation, Neusoft Medical Systems Co., Ltd., SurgicEye GmbH, Siemens Healthineers, GE Healthcare, Mediso Medical Imaging Systems Ltd., Digirad Corporation, CMR Naviscan Corporation, DDD Diagnostics, and Philips Healthcare. The nuclear imaging devices and equipment market is being restrained by strict regulations by the Nuclear Regulatory Commission (NRC) medical use. For instance, the NRC requires nuclear imaging equipment licensees to use and store radioactive materials to protect workers and common people by removing unwanted exposure, which has resulted in a relatively less number of nuclear imaging equipment being manufactured. Companies in the nuclear imaging devices and equipment market are using hybrid imaging technologies such as positron emission tomography/computed tomography (PET/CT), single-photon emission computed tomography/computed tomography (SPECT/CT), and positron emission tomography/magnetic resonance imaging (PET/MRI) for nuclear medical imaging. These hybrid systems provide precise images with better resolution and both morphological and physiological information in just one instance of testing. For instance, a SPECT/CT system for skeletal evaluation offers accurate localization and improves the specificity of information provided by CT. The Nuclear Regulatory Commission (NRC), USA regulates the manufacture and use of radioactive materials in nuclear imaging devices, as well as radiation therapy and research. It has agreements with 37 US states which allows them to regulate the use of certain radioactive materials by giving licenses to hospitals, clinics, and medical centres. The US-based Food and Drug Administration (FDA) also regulates products and procedures that are radiation-emitting. It reviews the safety and use of radiopharmaceuticals and machines like x-rays, which produce radiation but do not make or use radioactive material. In April 2020, TTG Imaging Solutions, LLC., a company operating in nuclear medicine equipment based in the United States acquired Nuclear Imaging Services and Molecular Imaging Specialists for an undisclosed amount. With this acquisition, The company wants to expand its portfolio in diagnostics imaging. Nuclear Imaging Services is a company operating in nuclear imaging based in texas and Molecular Imaging Specialists, a company operating in nuclear imaging devices and equipment based in the United States. Western Europe was the largest region in the nuclear imaging devices and equipment market in 2022. North America was the second-largest region in the nuclear imaging devices and equipment market. The regions covered in the nuclear imaging devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the nuclear imaging devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The nuclear imaging devices and equipment market consist of sales of SPECT (single-photon emission computed tomography) systems, hybrid PET systems, and planar scintigraphy imaging systems. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The nuclear imaging devices and equipment market research report is one of a series of new reports from The Business Research Company that provides nuclear imaging devices and equipment market statistics, including nuclear imaging devices and equipment industry global market size, regional shares, competitors with a nuclear imaging devices and equipment market share, detailed nuclear imaging devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the nuclear imaging devices and equipment industry. This nuclear imaging devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Dental equipment and supplies consist of tools, instruments, and supplies used by dentists, dental hygienists, and laboratories to provide dental treatment. The main types in the dental equipment and supplies are therapeutic dental equipment, general dental devices, and equipment, dental diagnostic imaging devices, and equipment, dental surgical devices, and equipment. Therapeutic dental equipment is used for the treatment of dental diseases. The type of expenditure used is public, private. The products used are instruments/equipment, disposables. The various end-users involved are hospitals and clinics, diagnostic laboratories, and others. The global dental equipment and supplies market is segmented - 1) By Type: Therapeutic Dental Equipment, General Dental Devices And Equipment, Dental Diagnostic Imaging Devices And Equipment, Dental Surgical Devices And Equipment 2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users 3) By Type of Expenditure: Public, Private 4) By Product: Instruments/Equipment, Disposables The global dental equipment and supplies market size grew from $22.36 billion in 2022 to $24.99 billion in 2023 at a compound annual growth rate (CAGR) of 11.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global dental equipment and supplies is expected to grow to $38.41 billion in 2027 at a CAGR of 11.3%. The growth in the older population is expected to drive the dental equipment and supplies market. The older population is prone to a number of dental problems and extensive tooth loss, which increases exponentially with age, thus generating demand for dental equipment and supplies, used for diagnostic, therapeutic and surgical purposes. For instance, the United Nations estimates that the population of older adults (aged 65 years or above) globally to increase from 703 million in 2019 to 1.5 billion by 2050. Additionally, in Japan, the percentage of seniors is expected to grow from 28% in 2019 to 38% in 2050. Hence, the increasing older population is expected to drive the growth of the dental equipment and supplies market during the forecast period. Major companies in the dental equipment and supplies market include Dentsply Sirona, Danaher, Carestream Health, 3M, Straumann. The dental industry is continuously incorporating advanced technologies for the manufacturing of dentures. Digital dentures deal with workflow involved in the fabrication of dentures which are prosthetic devices meant to replace missing teeth. This process utilizes software modules such as computer-aided design and computer-aided manufacturing (CAD/CAM) and materials to create precision-fitted dentures in short durations. The inclusion of this concept allows dental technicians to fabricate prostheses using material discs with quicker design time and better fit. Companies that offer digital dentures include AvaDent, DENTCA, Dentsply Sirona, Amann Girrbach. Asia-Pacific was the largest region in the global dental equipment and supplies market in 2022. Western Europe was the second-largest region in the global dental equipment and supplies market share. Africa. was the smallest region in the global dental equipment and supplies industry analysis. The regions covered in the dental equipment and supplies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the dental equipment and supplies market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The dental equipment and supplies market consists of sales of dental radiology equipment, dental surgical navigation systems, CAD/CAM equipment, dental chairs, and other dental devices that are used for treatment of dental disorders. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The dental equipment and supplies market research report is one of a series of new reports from The Business Research Company that provides dental equipment and supplies global market statistics, including dental equipment and supplies industry global market size, regional shares, competitors with a dental equipment and supplies global market share, detailed dental equipment and supplies market segments, market trends and opportunities, and any further data you may need to thrive in the dental equipment and supplies industry. This dental equipment and supplies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Dental diagnostic imaging devices and equipment create a visual representation of the inner tooth body for clinical analysis. These devices are used for better analysis of dental problems such as tooth decay, tooth erosion, and gum disease. The main methods in dental diagnostic imaging devices and equipment market are intraoral imaging and extraoral imaging. Intraoral imaging refers to the intraoral cameras that are used to provide accurate images of the teeth. The various technologies are X-Ray Systems, dental cone beam computed tomography, magnetic resonance imaging, and others. These are used in hospitals, dental clinics, forensic labs, and others. The global dental diagnostic imaging devices and equipment market is segmented - 1) By Method: Intraoral Imaging, Extraoral Imaging 2) By End Users: Hospitals, Dental Clinics, Forensic Labs, Other End Users 3) By Technology: X-Ray Systems, Dental Cone Beam Computed Tomography, Magnetic Resonance Imaging, Other Technologies The global dental diagnostic imaging devices and equipment market size will grow from $2.41 billion in 2022 to $2.72 billion in 2023 at a compound annual growth rate (CAGR) of 13.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global dental diagnostic imaging devices and equipment is expected to grow to $4.36 billion in 2027 at a CAGR of 12.5%. The growing awareness of dental health care has led to demand for a proper healthcare system with upgraded devices. The dental diagnostic imaging devices and equipment market help to meet the oral healthcare demands of people and will drive market growth. These imaging devices help to reduce shorten the recovery time for a patient and also result in less pain when compared to earlier methods of diagnosing dental problems. According to Adults Oral Health & Well-being Survey, 85% of Americans believe that oral health is extremely important among which only 15% were satisfied with their current oral health. This indicates that people look for better dental care now and are aware of the importance of oral healthcare which will drive the dental diagnostic imaging devices and equipment market growth. Major players in the dental diagnostic imaging devices and equipment market are Carestream Health Inc., Fujifilm Holdings Corporation, Hitachi Medical Corporation, Siemens Healthcare, GE Healthcare, Philips Healthcare, Hologic Inc., Canon, Shimadzu Corporation, and Toshiba Medical Systems Corporation. The lack of consumer awareness on the available dental diagnostic imaging devices in many developing economies is restraining the dental diagnostic imaging devices and equipment market growth. People in many developing countries tend to neglect dental problems due to a lack of awareness. This attitude affects the health and also the growth of the dental diagnostic imaging device market as the use and procurement of these devices are affected negatively. For example, WHO has provided technical and financial support to the Ministry of Public Health and Education is conducting a series of workshops and campaigns on oral health for schoolteachers in Kabul city. These workshops aim to raise awareness of oral health and prevention of negligence towards dental problems in the dental diagnostic imaging devices and equipment market. The need for precise diagnostic tools has given rise to innovation in dental imaging technology such as cone beam computed tomography (CBCT) and magnetic resonance imaging and others. These new techniques have helped in a better examination of complex facial structures and early diagnosis of dental diseases. For example, the All-India Institute of Medical Sciences (AIIMS) started the use of a Cone Beam CT (CBCT) scan facility that would help dental surgeons in increasing the efficiency of their dental surgeries. These devices provide a 3D image of the patient's jaw to get precise knowledge of the problem before the surgery is performed and help in safe and better treatment outcomes. Various government reforms and organizations are currently focusing on dental care safety and aim to reduce oral health care problems. For example, FDA's Center for Devices and radiological health is responsible for regulating firms that manufacture, repackage or import medical devices sold in the United States. Also, CDRH regulates medical devices such as radiation-emitting electronic products such as lasers, x-ray systems, and ultrasound equipment. Asia-Pacific was the largest region in the global dental diagnostic imaging devices and equipment market in 2022. Western Europe was the second-largest region in dental diagnostic imaging devices and equipment market report. The regions covered in the dental diagnostic imaging devices and equipment industry report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the dental diagnostic imaging devices market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, and Australia. Dental diagnostic imaging devices and equipment consists of sales of Extraoral Imaging Systems, (Panoramic Systems, Panoramic & Cephalometric Systems, 3d CBCT Systems) And Intraoral Imaging Systems (Intraoral X-Ray Systems, Intraoral Sensors, and Intraoral PSP Systems) for dental diagnostic imaging that are used for diagnosis of dental diseases. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The dental diagnostic imaging devices and equipment market research report is one of a series of new reports from The Business Research Company that provides dental diagnostic imaging devices and equipment market statistics, including dental diagnostic imaging devices and equipment industry global market size, regional shares, competitors with a dental diagnostic imaging devices and equipment market share, detailed dental diagnostic imaging devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the dental diagnostic imaging devices and equipment industry. This dental diagnostic imaging devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Diagnostic And Monitoring Ophthalmic Devices And Equipment Market Definition

The diagnostic and monitoring ophthalmic devices and equipment market consists of sales of diagnostic and monitoring ophthalmic devices and equipment and related services by entities (organizations, sole traders and partnerships) that manufacture diagnostic and monitoring ophthalmic devices and equipment. The diagnostic and monitoring ophthalmic devices are used for the diagnosis and monitoring of diseases related to the retina and cornea by measuring affix lenses and refractive errors. These devices also help to identify the power of the intra ocular lens (IOLs) and analyze the visual field. These devices include ultrasound imaging systems, optical coherence tomography scanners, ophthalmoscopes, corneal topographers, specular microscopes, slit lamps, fundus cameras, anomaloscope, haploscope, ophthalmic lens gauge, stereopsis measuring Instrument, retinoscopes, stereoscope and others.

The diagnostic devices (or) equipment market consists of sales of diagnostic equipment and related services by entities (organizations, sole traders, and partnerships) that are used to identify the nature or cause of a certain phenomenon, usually related to a medical condition. Some of the devices include magnetic resonance imaging apparatuses, temperature sensors or pacemakers. The main types of diagnostic devices or equipment are x-rayed systems, ultrasound systems, computed tomography (CT) scanners, magnetic resonance imaging systems, cardiovascular monitoring and diagnostic devices, and nuclear imaging devices. X-rays refer to a type of electromagnetic radiation, just like visible light. The mobility is stationary and mobile and is used in hospitals and diagnostic imaging centers. The global diagnostic equipment market size is expected to grow from $43.81 billion in 2021 to $47.74 billion in 2022 at a compound annual growth rate (CAGR) of 9.0%. The global diagnostic equipment market size is expected to grow to $59.46 billion in 2026 at a compound annual growth rate (CAGR) of 5.6%. An increase in the geriatric population is expected to propel the growth of the diagnostic devices market going forward. Older people are likely to suffer from diseases such as diabetes, cancer, and arthritis, among others, which would increase the demand for diagnostic devices. For instance, in 2020, according to the United Nations, a US-based intergovernmental organization, there are approximately 727 million persons are aged 65 years and above worldwide, and expected to reach approximately 1.5 billion persons by 2050. Therefore, the increase in the geriatric population is driving the growth of the diagnostic devices market.  The emergence of routine diagnostic kits is a key trend gaining popularity in the diagnostic devices market. Companies operating in the market are focusing on developing diagnostic kits to gain market coverage. For instance, in March 2022, Mylab Discovery Solutions, an India-based healthcare company, is set to launch an entire range of routine diagnostic kits and devices in conventional and point-of-care formats. Immunology, Biochemistry, and Haematology are the three main market sub-segments represented by the devices and kits included in them.  In July 2021, DiaSorin S.p.A., an Italy-based biotechnology company, acquired Luminex Corporation for a deal amount of $1.8 billion. Through the acquisition, DiaSorin would gain access to Luminex’s multiplexing technology and a portfolio that would strengthen its existing offering while expanding the group's presence in the United States. Further, this agreement would give the life science sector access to Luminex's applications, promoting academic and scientific research, improving collaboration with biopharma businesses, and boosting access to clinical multiplexing assays for upcoming Value-Based Care initiatives. Luminex Corporation is a US-based biotechnology company that manufactures medical diagnostic devices. Major players in the diagnostic equipment market include Philips Healthcare, Hitachi Medical Systems, Fujifilm Holdings, Siemens Healthcare, and GE Healthcare. The regions covered in global diagnostic equipment market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the diagnostic devices or equipment market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The global diagnostic equipment market is segmented - 1) By Type: X-Ray Systems, Ultrasound Systems, Computed Tomography (CT) Scanners, Magnetic Resonance Imaging Systems, Cardiovascular Monitoring and Diagnostic Devices, and Nuclear Imaging Device 2) By Mobility: Stationary, Mobile 3) By End User: Hospitals, Diagnostic imaging centres